IDENTIFICATION OF GENETIC SIGNATURES AND IMMUNE MECHANISMS THAT DEFINE THERAPEUTIC RESPONSE AND FAILURE TO ANTI-INTEGRIN THERAPY WITH VEDOLIZUMAB IN IBD PATIENTS

Timo Rath  1     Ulrike Billmeier  1     Fulvia Ferrazzii  2     Michael Vieth     Arif Ekici     Markus F. Neurath     Raja Atreya    
1 Friedrich-Alexander University Erlangen-Nuremberg,Department of Medicine I, Division of Gastroenterology,Erlangen,Germany
2 Friedrich-Alexander University Erlangen-Nuremberg,Department of Human Genetics,Erlangen,Germa

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing